These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 35181926)

  • 1. Capturing the real-world benefit of residual β-cell function during clinically important time-periods in established Type 1 diabetes.
    Taylor GS; Shaw AC; Smith K; Wason J; McDonald TJ; Oram RA; Stevenson E; Shaw JAM; West DJ
    Diabet Med; 2022 May; 39(5):e14814. PubMed ID: 35181926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postexercise Glycemic Control in Type 1 Diabetes Is Associated With Residual β-Cell Function.
    Taylor GS; Smith K; Capper TE; Scragg JH; Bashir A; Flatt A; Stevenson EJ; McDonald TJ; Oram RA; Shaw JA; West DJ
    Diabetes Care; 2020 Oct; 43(10):2362-2370. PubMed ID: 32747405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A single-blind, randomised, crossover study to reduce hypoglycaemia risk during postprandial exercise with closed-loop insulin delivery in adults with type 1 diabetes: announced (with or without bolus reduction) vs unannounced exercise strategies.
    Tagougui S; Taleb N; Legault L; Suppère C; Messier V; Boukabous I; Shohoudi A; Ladouceur M; Rabasa-Lhoret R
    Diabetologia; 2020 Nov; 63(11):2282-2291. PubMed ID: 32740723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dietary determinants of postprandial blood glucose control in adults with type 1 diabetes on a hybrid closed-loop system.
    Vetrani C; Calabrese I; Cavagnuolo L; Pacella D; Napolano E; Di Rienzo S; Riccardi G; Rivellese AA; Annuzzi G; Bozzetto L
    Diabetologia; 2022 Jan; 65(1):79-87. PubMed ID: 34689215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycaemic load versus carbohydrate counting for insulin bolus calculation in patients with type 1 diabetes on insulin pump.
    Bozzetto L; Giorgini M; Alderisio A; Costagliola L; Giacco A; Riccardi G; Rivellese AA; Annuzzi G
    Acta Diabetol; 2015 Oct; 52(5):865-71. PubMed ID: 25697600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous glucose monitoring for patients with type 1 diabetes and impaired awareness of hypoglycaemia (IN CONTROL): a randomised, open-label, crossover trial.
    van Beers CA; DeVries JH; Kleijer SJ; Smits MM; Geelhoed-Duijvestijn PH; Kramer MH; Diamant M; Snoek FJ; Serné EH
    Lancet Diabetes Endocrinol; 2016 Nov; 4(11):893-902. PubMed ID: 27641781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In children and young people with type 1 diabetes using Pump therapy, an additional 40% of the insulin dose for a high-fat, high-protein breakfast improves postprandial glycaemic excursions: A cross-over trial.
    Smith TA; Smart CE; Fuery MEJ; Howley PP; Knight BA; Harris M; King BR
    Diabet Med; 2021 Jul; 38(7):e14511. PubMed ID: 33405297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-protein meals require 30% additional insulin to prevent delayed postprandial hyperglycaemia.
    Paterson MA; Smart CEM; Howley P; Price DA; Foskett DC; King BR
    Diabet Med; 2020 Jul; 37(7):1185-1191. PubMed ID: 32298501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lower nocturnal blood glucose response to a potato-based mixed evening meal compared to rice in individuals with type 2 diabetes.
    Devlin BL; Parr EB; Radford BE; Hawley JA
    Clin Nutr; 2021 Apr; 40(4):2200-2209. PubMed ID: 33069511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. For a high fat, high protein breakfast, preprandial administration of 125% of the insulin dose improves postprandial glycaemic excursions in people with type 1 diabetes using multiple daily injections: A cross-over trial.
    Smith TA; Smart CE; Howley PP; Lopez PE; King BR
    Diabet Med; 2021 Jul; 38(7):e14512. PubMed ID: 33421203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of postprandial exercise on blood glucose levels in adults with type 1 diabetes: a review.
    Helleputte S; Yardley JE; Scott SN; Stautemas J; Jansseune L; Marlier J; De Backer T; Lapauw B; Calders P
    Diabetologia; 2023 Jul; 66(7):1179-1191. PubMed ID: 37014379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Day and night glycaemic control with a bionic pancreas versus conventional insulin pump therapy in preadolescent children with type 1 diabetes: a randomised crossover trial.
    Russell SJ; Hillard MA; Balliro C; Magyar KL; Selagamsetty R; Sinha M; Grennan K; Mondesir D; Ekhlaspour L; Zheng H; Damiano ER; El-Khatib FH
    Lancet Diabetes Endocrinol; 2016 Mar; 4(3):233-243. PubMed ID: 26850709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of dietary protein on postprandial blood glucose levels in individuals with Type 1 diabetes mellitus using intensive insulin therapy.
    Paterson MA; Smart CE; Lopez PE; McElduff P; Attia J; Morbey C; King BR
    Diabet Med; 2016 May; 33(5):592-8. PubMed ID: 26499756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ascorbic acid supplementation improves postprandial glycaemic control and blood pressure in individuals with type 2 diabetes: Findings of a randomized cross-over trial.
    Mason SA; Rasmussen B; van Loon LJC; Salmon J; Wadley GD
    Diabetes Obes Metab; 2019 Mar; 21(3):674-682. PubMed ID: 30394006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A low-glycemic index meal and bedtime snack prevents postprandial hyperglycemia and associated rises in inflammatory markers, providing protection from early but not late nocturnal hypoglycemia following evening exercise in type 1 diabetes.
    Campbell MD; Walker M; Trenell MI; Stevenson EJ; Turner D; Bracken RM; Shaw JA; West DJ
    Diabetes Care; 2014 Jul; 37(7):1845-53. PubMed ID: 24784832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Control of postprandial hyperglycemia: optimal use of short-acting insulin secretagogues.
    Carroll MF; Izard A; Riboni K; Burge MR; Schade DS
    Diabetes Care; 2002 Dec; 25(12):2147-52. PubMed ID: 12453952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multicenter outpatient dinner/overnight reduction of hypoglycemia and increased time of glucose in target with a wearable artificial pancreas using modular model predictive control in adults with type 1 diabetes.
    Del Favero S; Place J; Kropff J; Messori M; Keith-Hynes P; Visentin R; Monaro M; Galasso S; Boscari F; Toffanin C; Di Palma F; Lanzola G; Scarpellini S; Farret A; Kovatchev B; Avogaro A; Bruttomesso D; Magni L; DeVries JH; Cobelli C; Renard E;
    Diabetes Obes Metab; 2015 May; 17(5):468-76. PubMed ID: 25600304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Home use of a bihormonal bionic pancreas versus insulin pump therapy in adults with type 1 diabetes: a multicentre randomised crossover trial.
    El-Khatib FH; Balliro C; Hillard MA; Magyar KL; Ekhlaspour L; Sinha M; Mondesir D; Esmaeili A; Hartigan C; Thompson MJ; Malkani S; Lock JP; Harlan DM; Clinton P; Frank E; Wilson DM; DeSalvo D; Norlander L; Ly T; Buckingham BA; Diner J; Dezube M; Young LA; Goley A; Kirkman MS; Buse JB; Zheng H; Selagamsetty RR; Damiano ER; Russell SJ
    Lancet; 2017 Jan; 389(10067):369-380. PubMed ID: 28007348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interrupting prolonged sitting with frequent short bouts of light-intensity activity in people with type 1 diabetes improves glycaemic control without increasing hypoglycaemia: The SIT-LESS randomised controlled trial.
    Campbell MD; Alobaid AM; Hopkins M; Dempsey PC; Pearson SM; Kietsiriroje N; Churm R; Ajjan RA
    Diabetes Obes Metab; 2023 Dec; 25(12):3589-3598. PubMed ID: 37622406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved postprandial metabolic control after subcutaneous injection of a short-acting insulin analog in IDDM of short duration with residual pancreatic beta-cell function.
    Pampanelli S; Torlone E; Ialli C; Del Sindaco P; Ciofetta M; Lepore M; Bartocci L; Brunetti P; Bolli GB
    Diabetes Care; 1995 Nov; 18(11):1452-9. PubMed ID: 8722069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.